MAP Pharmaceuticals, Inc. Announces Full Exercise Of Underwriter's Option To Purchase Additional Shares Of Common Stock
Christopher Y. Chai, Sr. Vice President and Chief Financial Officer of MAP Pharmaceuticals, Inc., (650) 386-3107; or media,
Lisa Borland, (650) 386-3122,
Copyright (C) 2012 PR Newswire. All rights reserved
SOURCE MAP Pharmaceuticals, Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts